The North America Pancrelipase Market would witness market growth of 3.8% CAGR during the forecast period (2023-2030).
Pancrelipase, a blend of lipase, protease, and amylase, mimics the natural digestive processes in the pancreas. It is prescribed primarily for patients with conditions such as cystic fibrosis, chronic pancreatitis, and pancreatic cancer, where the pancreas fails to produce adequate digestive enzymes. This enzyme therapy aids in breaking fats, proteins, and carbohydrates, facilitating nutrient absorption and maintaining overall digestive health.
An exocrine pancreatic insufficiency-related class of drugs is used to treat malabsorption and abdominal pain. It is utilized when the pancreas is unable to produce or release sufficient amounts of digestive enzymes into the small intestines to adequately digest the food (conditions like chronic pancreatitis, cystic fibrosis, cancer of the pancreas, post-pancreatectomy, post-gastrointestinal bypass surgery). This medicine is a combination of lipase, protease, and amylase. Purified porcine pancreatic lipase, amylase, and protease enzymes make this drug.
According to the Canadian Institute for Health Information, in 2023, total health expenditures in Canada are projected to increase by 2.8%, compared to a modest 1.5% increase in 2022. By 2023, Canadian health expenditures are projected to total $344 billion, or $8,740 per Canadian. Additionally, by 2023, health-related expenses are projected to account for 12.1% of Canada's gross domestic product (GDP). Higher healthcare spending allows for investments in advanced healthcare services, including diagnostic facilities and specialized clinics. Improved access to healthcare services facilitates early diagnosis of pancreatic disorders, leading to increased demand for therapy. Thus, the above aspects will expand the market growth across the region in the upcoming years.
The US market dominated the North America Pancrelipase Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $899.3 Million by 2030. The Canada market is experiencing a CAGR of 6.2% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 5.3% during (2023 - 2030).
Free Valuable Insights: The Pancrelipase Market is Predict to reach $2.6 Billion by 2030, at a CAGR of 4.7%
Based on Age, the market is segmented into Adults & Geriatrics, and Children. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on Application, the market is segmented into Chronic Pancreatitis, Cystic Fibrosis, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Organon & Co.
- Digestive Care, Inc.
- AbbVie, Inc.
- Vivus LLC
- Laboratorio Opoterápico Argentino S.A.
- Nestle S.A
- Scientific Protein Laboratories, LLC (Hepalink)
North America Pancrelipase Market Report Segmentation
By Age
- Adults & Geriatrics
- Children
By Distribution Channel
- Drug Store & Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Application
- Chronic Pancreatitis
- Cystic Fibrosis
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Pancrelipase Market, by Age
1.4.2 North America Pancrelipase Market, by Distribution Channel
1.4.3 North America Pancrelipase Market, by Application
1.4.4 North America Pancrelipase Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. North America Pancrelipase Market by Age
4.1 North America Adults & Geriatrics Market by Country
4.2 North America Children Market by Country
Chapter 5. North America Pancrelipase Market by Distribution Channel
5.1 North America Drug Store & Retail Pharmacies Market by Country
5.2 North America Hospital Pharmacies Market by Country
5.3 North America Online Pharmacies Market by Country
Chapter 6. North America Pancrelipase Market by Application
6.1 North America Chronic Pancreatitis Market by Country
6.2 North America Cystic Fibrosis Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Pancrelipase Market by Country
7.1 US Pancrelipase Market
7.1.1 US Pancrelipase Market by Age
7.1.2 US Pancrelipase Market by Distribution Channel
7.1.3 US Pancrelipase Market by Application
7.2 Canada Pancrelipase Market
7.2.1 Canada Pancrelipase Market by Age
7.2.2 Canada Pancrelipase Market by Distribution Channel
7.2.3 Canada Pancrelipase Market by Application
7.3 Mexico Pancrelipase Market
7.3.1 Mexico Pancrelipase Market by Age
7.3.2 Mexico Pancrelipase Market by Distribution Channel
7.3.3 Mexico Pancrelipase Market by Application
7.4 Rest of North America Pancrelipase Market
7.4.1 Rest of North America Pancrelipase Market by Age
7.4.2 Rest of North America Pancrelipase Market by Distribution Channel
7.4.3 Rest of North America Pancrelipase Market by Application
Chapter 8. Company Profiles
8.1 Organon & Co.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.2 Digestive Care, Inc.
8.2.1 Company Overview
8.3 Laboratorio Opoterápico Argentino S.A.
8.3.1 Company Overview
8.4 Scientific Protein Laboratories, LLC (Hepalink)
8.4.1 Company Overview
8.5 AbbVie, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Vivus LLC
8.6.1 Company Overview
8.7 Nestle S.A
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
TABLE 1 North America Pancrelipase Market, 2019 - 2022, USD Million
TABLE 2 North America Pancrelipase Market, 2023 - 2030, USD Million
TABLE 3 North America Pancrelipase Market by Age, 2019 - 2022, USD Million
TABLE 4 North America Pancrelipase Market by Age, 2023 - 2030, USD Million
TABLE 5 North America Adults & Geriatrics Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Adults & Geriatrics Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Children Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Children Market by Country, 2023 - 2030, USD Million
TABLE 9 North America Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 10 North America Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 11 North America Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 12 North America Drug Store & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 13 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 15 North America Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Online Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 17 North America Pancrelipase Market by Application, 2019 - 2022, USD Million
TABLE 18 North America Pancrelipase Market by Application, 2023 - 2030, USD Million
TABLE 19 North America Chronic Pancreatitis Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Chronic Pancreatitis Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Cystic Fibrosis Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Cystic Fibrosis Market by Country, 2023 - 2030, USD Million
TABLE 23 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 25 North America Pancrelipase Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Pancrelipase Market by Country, 2023 - 2030, USD Million
TABLE 27 US Pancrelipase Market, 2019 - 2022, USD Million
TABLE 28 US Pancrelipase Market, 2023 - 2030, USD Million
TABLE 29 US Pancrelipase Market by Age, 2019 - 2022, USD Million
TABLE 30 US Pancrelipase Market by Age, 2023 - 2030, USD Million
TABLE 31 US Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 32 US Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 33 US Pancrelipase Market by Application, 2019 - 2022, USD Million
TABLE 34 US Pancrelipase Market by Application, 2023 - 2030, USD Million
TABLE 35 Canada Pancrelipase Market, 2019 - 2022, USD Million
TABLE 36 Canada Pancrelipase Market, 2023 - 2030, USD Million
TABLE 37 Canada Pancrelipase Market by Age, 2019 - 2022, USD Million
TABLE 38 Canada Pancrelipase Market by Age, 2023 - 2030, USD Million
TABLE 39 Canada Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 40 Canada Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 41 Canada Pancrelipase Market by Application, 2019 - 2022, USD Million
TABLE 42 Canada Pancrelipase Market by Application, 2023 - 2030, USD Million
TABLE 43 Mexico Pancrelipase Market, 2019 - 2022, USD Million
TABLE 44 Mexico Pancrelipase Market, 2023 - 2030, USD Million
TABLE 45 Mexico Pancrelipase Market by Age, 2019 - 2022, USD Million
TABLE 46 Mexico Pancrelipase Market by Age, 2023 - 2030, USD Million
TABLE 47 Mexico Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 48 Mexico Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 49 Mexico Pancrelipase Market by Application, 2019 - 2022, USD Million
TABLE 50 Mexico Pancrelipase Market by Application, 2023 - 2030, USD Million
TABLE 51 Rest of North America Pancrelipase Market, 2019 - 2022, USD Million
TABLE 52 Rest of North America Pancrelipase Market, 2023 - 2030, USD Million
TABLE 53 Rest of North America Pancrelipase Market by Age, 2019 - 2022, USD Million
TABLE 54 Rest of North America Pancrelipase Market by Age, 2023 - 2030, USD Million
TABLE 55 Rest of North America Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 56 Rest of North America Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 57 Rest of North America Pancrelipase Market by Application, 2019 - 2022, USD Million
TABLE 58 Rest of North America Pancrelipase Market by Application, 2023 - 2030, USD Million
TABLE 59 Key Information – Organon & co.
TABLE 60 Key Information – Digestive Care, Inc.
TABLE 61 Key Information – Laboratorio Opoterápico Argentino S.A.
TABLE 62 Key Information – Scientific Protein Laboratories, LLC
TABLE 63 Key information – AbbVie, Inc.
TABLE 64 Key Information – Vivus LLC
TABLE 65 Key Information – Nestle S.A
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Pancrelipase Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Pancrelipase Market
FIG 4 Porter’s Five Forces Analysis – Pancrelipase Market
FIG 5 North America Pancrelipase Market share by Age, 2022
FIG 6 North America Pancrelipase Market share by Age, 2030
FIG 7 North America Pancrelipase Market by Age, 2019 - 2030, USD Million
FIG 8 North America Pancrelipase Market share by Distribution Channel, 2022
FIG 9 North America Pancrelipase Market share by Distribution Channel, 2030
FIG 10 North America Pancrelipase Market by Distribution Channel, 2019 - 2030, USD Million
FIG 11 North America Pancrelipase Market share by Application, 2022
FIG 12 North America Pancrelipase Market share by Application, 2030
FIG 13 North America Pancrelipase Market by Application, 2019 - 2030, USD Million
FIG 14 North America Pancrelipase Market share by Country, 2022
FIG 15 North America Pancrelipase Market share by Country, 2030
FIG 16 North America Pancrelipase Market by Country, 2019 - 2030, USD Million
FIG 17 Swot Analysis: AbbVie, Inc.
FIG 18 SWOT Analysis: Nestle S.A